These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 16538926

  • 21. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
    Schaeffer J, Floege J, Ehlerding G, Koch KM.
    Nephrol Dial Transplant; 1995; 10 Suppl 3():4-8. PubMed ID: 7494614
    [Abstract] [Full Text] [Related]

  • 22. Hemodialysis-related amyloidosis: Is it still relevant?
    Kaneko S, Yamagata K.
    Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
    [Abstract] [Full Text] [Related]

  • 23. Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.
    Gejyo F, Kawaguchi Y, Hara S, Nakazawa R, Azuma N, Ogawa H, Koda Y, Suzuki M, Kaneda H, Kishimoto H, Oda M, Ei K, Miyazaki R, Maruyama H, Arakawa M, Hara M.
    Artif Organs; 2004 Apr; 28(4):371-80. PubMed ID: 15084199
    [Abstract] [Full Text] [Related]

  • 24. Nontransplant therapy for dialysis-related amyloidosis.
    Copley JB, Lindberg JS.
    Semin Dial; 2001 Apr; 14(2):94-8. PubMed ID: 11264774
    [Abstract] [Full Text] [Related]

  • 25. Beta-2 microglobulin in ESRD: an in-depth review.
    Winchester JF, Salsberg JA, Levin NW.
    Adv Ren Replace Ther; 2003 Oct; 10(4):279-309. PubMed ID: 14681859
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF, McCarthy M, Howse ML, Williams PS.
    Ren Fail; 2007 Oct; 29(6):653-9. PubMed ID: 17763158
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dialysis-related Amyloidosis: Is It Gone or Should It Be?
    Labriola L, Jadoul M.
    Semin Dial; 2017 May; 30(3):193-196. PubMed ID: 28264226
    [Abstract] [Full Text] [Related]

  • 34. [Diagnosis of and therapy for patients with dialysis amyloidosis].
    Homma N, Gejyo F.
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():348-52. PubMed ID: 15250322
    [No Abstract] [Full Text] [Related]

  • 35. [Beta 2 microglobulin. 2: Dialysis-associated amyloidosis].
    Schwarz A, Walz G.
    Fortschr Med; 1988 May 30; 106(16):334-7. PubMed ID: 3042564
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The pathology and changing epidemiology of dialysis-related cardiac beta-2 microglobulin amyloidosis.
    Morris AD, Smith RN, Stone JR.
    Cardiovasc Pathol; 2019 May 30; 42():30-35. PubMed ID: 31226597
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.